TB 500 vs BPC 157: Comprehensive comparison of healing peptides Modulatory effects of BPC 157 on vasomotor tone and the activation of Src Caveolin 1 endothelial nitric oxide synthase pathway Scientific Reports BPC 157 and TB 500: Unapproved and Regulated Patrick J Moloney posted on the topic LinkedIn The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization Peptide BPC 157 Intra V